MONARCH 2: Overall survival of abemaciclib plus fulvestrant in patients with HR+, HER2- advanced breast cancer
暂无分享，去创建一个
P. Neven | G. Sledge | X. Pivot | Kenichi Inoue | N. Masuda | A. Llombart-Cussac | P. Conte | P. Kaufman | K. Hurt | H. Koh | J. Sohn | S. Barriga | M. Toi | S. Johnston | M. Okera | Martin Frenzel | Yi Lu | E. Grischke | O. Burdaeva